Neoplasm Recurrence, Local
"Neoplasm Recurrence, Local" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site.
| Descriptor ID |
D009364
|
| MeSH Number(s) |
C04.697.655 C23.550.727.655
|
| Concept/Terms |
Neoplasm Recurrence, Local- Neoplasm Recurrence, Local
- Local Neoplasm Recurrences
- Locoregional Neoplasm Recurrence
- Recurrences, Local Neoplasm
- Neoplasm Recurrences, Local
- Recurrence, Local Neoplasm
- Recurrence, Locoregional Neoplasm
- Local Neoplasm Recurrence
- Neoplasm Recurrence, Locoregional
- Locoregional Neoplasm Recurrences
- Neoplasm Recurrences, Locoregional
- Recurrences, Locoregional Neoplasm
|
Below are MeSH descriptors whose meaning is more general than "Neoplasm Recurrence, Local".
Below are MeSH descriptors whose meaning is more specific than "Neoplasm Recurrence, Local".
This graph shows the total number of publications written about "Neoplasm Recurrence, Local" by people in this website by year, and whether "Neoplasm Recurrence, Local" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 8 | 25 | 33 |
| 1995 | 17 | 27 | 44 |
| 1996 | 19 | 37 | 56 |
| 1997 | 13 | 28 | 41 |
| 1998 | 16 | 40 | 56 |
| 1999 | 22 | 27 | 49 |
| 2000 | 20 | 35 | 55 |
| 2001 | 26 | 52 | 78 |
| 2002 | 39 | 38 | 77 |
| 2003 | 56 | 46 | 102 |
| 2004 | 57 | 52 | 109 |
| 2005 | 52 | 66 | 118 |
| 2006 | 61 | 65 | 126 |
| 2007 | 62 | 70 | 132 |
| 2008 | 68 | 61 | 129 |
| 2009 | 44 | 85 | 129 |
| 2010 | 69 | 82 | 151 |
| 2011 | 75 | 79 | 154 |
| 2012 | 88 | 49 | 137 |
| 2013 | 83 | 95 | 178 |
| 2014 | 107 | 67 | 174 |
| 2015 | 114 | 89 | 203 |
| 2016 | 108 | 53 | 161 |
| 2017 | 112 | 77 | 189 |
| 2018 | 111 | 84 | 195 |
| 2019 | 95 | 83 | 178 |
| 2020 | 105 | 121 | 226 |
| 2021 | 67 | 158 | 225 |
| 2022 | 14 | 167 | 181 |
| 2023 | 11 | 159 | 170 |
| 2024 | 35 | 54 | 89 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplasm Recurrence, Local" by people in Profiles.
-
Clinical Variables Influencing Outcomes in Patients with Atypical Intradermal Smooth Muscle Neoplasms (Formerly Cutaneous Leiomyosarcomas): Single-Institution Study of 95 Surgical Patients. Ann Surg Oncol. 2024 Nov; 31(12):7950-7956.
-
Postoperative Complications Result in Poor Oncological Outcomes: What Is the Evidence? Curr Oncol. 2024 Aug 15; 31(8):4632-4655.
-
Comprehensive molecular characterization of early stage grade 3 endometrioid endometrial adenocarcinoma. Gynecol Oncol. 2024 Oct; 189:138-145.
-
ENGOT-EN20/GOG-3083/XPORT-EC-042 - A phase III, randomized, placebo-controlled, double-blind, multicenter trial of selinexor in maintenance therapy after systemic therapy for patients with p53 wild-type, advanced, or recurrent endometrial carcinoma: rationale, methods, and trial design. Int J Gynecol Cancer. 2024 Aug 05; 34(8):1283-1289.
-
Phase 1 study of NEDD8 activating enzyme inhibitor pevonedistat in combination with chemotherapy in pediatric patients with recurrent or refractory solid tumors (ADVL1615). Eur J Cancer. 2024 Sep; 209:114241.
-
Interreader and Intrareader Reproducibility of 18F-Flotufolastat Image Interpretation in Patients with Newly Diagnosed or Recurrent Prostate Cancer: Data from Two Phase 3 Prospective Multicenter Studies. J Nucl Med. 2024 Aug 01; 65(8):1239-1243.
-
Margin Width and Local Recurrence in Patients with Phyllodes Tumors of the Breast. Ann Surg Oncol. 2024 Nov; 31(12):8048-8056.
-
Patient-Reported Outcomes 10 Years After Breast-Conserving Surgery for Early-Stage Breast Cancer. Ann Surg Oncol. 2024 Oct; 31(10):6831-6840.
-
Internal Mammary Lymphadenopathy Does Not Impact Oncologic Outcomes in Patients Treated with Neoadjuvant Chemotherapy: Results from the I-SPY2 Clinical Trial. Ann Surg Oncol. 2024 Oct; 31(11):7420-7428.
-
Lacrimal Gland Adenocarcinoma Clinicopathologic Features and Outcomes Compared With Those of Lacrimal Gland Adenoid Cystic Carcinoma. Ophthalmic Plast Reconstr Surg. 2024 Jul-Aug 01; 40(4):419-425.